Ink-Jet Printing of Viable
Cells
This patented technology describes the utilization of
ink-jet printing of living cells (eukaryotic, prokaryotic, cell aggregates,
etc.) for the creation of 2-dimnsional or layered 3-dimension arrays of cells
and supporting polymeric material. These printed arrays can be used for study of
cell interaction, for the screening of drugs or materials, or for the automated
ex-vivo creation of viable tissues and organs.
Issued
patent 7,051,654 is a broad patent fundamental to the emerging field of
biofabrication.
o
Patented claims include multiple ink-jet
mechanisms (piezo electric, acoustic,
thermal)
o
Patented claims include eukaryotic and
prokaryotic cell types and combinations
o
Patented claims include printing of single
cells or cell aggregates
o
Patented claims include printing cells
within or onto supporting substrate including crosslinkble gels (i.e. collagen,
agar, hydrogel polymers and combinations).
Applications
- Biofabrication [i.e. the ex vivo
construction of viable tissue or organs for study or for therapeutic
applications]
- Rapid and automated creation of cellular
arrays for high throughput screening
- Bioprinter
products
- Study of cell to cell
interactions
Benefits
·
Broad patented technology fundamental to the
emerging field of biofabrication
·
Flexible technology that can enable many
applications.
Protection
Status: Issued
US Utility Patent #7,051,654
Licensing
Status: This
technology is available for licensing.
Additional
Terms: Tissue
Engineering, three dimensional, biofabrication, array, high-throughput
screening
CURF
ID:
01-025